◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

Grand Pharmaceutical Group Limited (0512) Financial History

Name: Grand Pharmaceutical Group Limited (0512) financial statement history
Creator: TickerBase
License: https://creativecommons.org/licenses/by/4.0/

4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

Healthcare · Drug Manufacturers - Specialty & Generic · DATA UPDATED 2026-08-10

Grand Pharmaceutical Group Limited (0512) operates in the Drug Manufacturers - Specialty & Generic industry and is headquartered in Central, Hong Kong with about 12,614 employees. Its market capitalization is roughly HKD 19 billion. In the fiscal year ended 2025-12-31, 0512 reported HKD 12.3B in revenue and HKD 1.2B in net income.

Grand Pharmaceutical Group Limited, an investment holding company, engages in the research and development, manufacture, and sale of pharmaceutical preparations and medical devices, biotechnology and healthcare products, and pharmaceutical raw materials.

Interactive charts & full statements →

0512 Revenue & Earnings History — Annual Income Statement

Income statement	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Total Revenue	HKD 12.3B	HKD 11.6B	HKD 10.5B	HKD 9.6B	—
Gross Profit	HKD 6.8B	HKD 6.7B	HKD 6.5B	HKD 6.0B	—
Operating Income (EBIT)	HKD 1.7B	HKD 2.2B	HKD 2.8B	HKD 2.7B	—
Net Income	HKD 1.2B	HKD 2.5B	HKD 1.9B	HKD 2.1B	—

HKD; HKDM / HKDB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

0512 Free Cash Flow History

Cash flow	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Dividends Paid	(HKD 910M)	(HKD 910M)	(HKD 497M)	(HKD 390M)	—

HKD; HKDM / HKDB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

0512 Balance Sheet History

Balance sheet	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Total Assets	HKD 27.2B	HKD 25.0B	HKD 22.5B	HKD 22.4B	—
Total Liabilities	HKD 10.0B	HKD 8.5B	HKD 7.2B	HKD 8.2B	—

HKD; HKDM / HKDB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive 0512 viewer.

Other Companies in Drug Manufacturers - Specialty & Generic

3320 · China Resources Pharmaceutical Group Limited — $30 billion
0867 · China Medical System Holdings Limited — $30 billion
1513 · Livzon Pharmaceutical Group Inc. — $23 billion
6887 · Sunshine Lake Pharma Co., Ltd. — $20 billion
4538 · Fuso Pharmaceutical Industries,Ltd. — $19 billion
3933 · The United Laboratories International Holdings Limited — $18 billion
0013 · HUTCHMED (China) Limited — $17 billion
2929 · Pharma Foods International Co., Ltd. — $17 billion

← 0511 All “0-9” companies 0513 →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.